Novo Nordisk A/S
Overview
Novo Nordisk A/S is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. The company is also involved in the development and manufacture of treatments for obesity, hemophilia, growth disorders, and other serious chronic conditions.
Therapeutic areas
FDA compliance signals
5 FDA enforcement records linked to this company.
- 4832013-09-03
Procedures for sterile drug products
- 4832013-09-03
Complaint Handling Procedure
- 4832013-09-03
Scientifically sound laboratory controls
- 4832013-09-03
Complete test data included in records
- warning_letter2012-12-12
FDA Warning Letter (drug product)
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.